FARMINGDALE, N.Y., May 4, 2011 /PRNewswire/ — Misonix, Inc.
(NASDAQ:
MSON), a medical device company that designs, manufactures, and
markets innovative, therapeutic, ultrasonic products worldwide for
wound debridement, cosmetic surgery, neurosurgery, laparoscopic
surgery, and other surgical and medical applications, announced
today that it will present at the MDB Capital Bright Lights
Conference on Wednesday, May 11, 2011 at the Le Parker Meridien
Hotel in New York City. Michael A. McManus, Jr., President
and Chief Executive Officer, will address the conference at 11:30
AM Eastern time to discuss the Company’s business strategy and
historical financial performance.
Bright Lights is the only conference of its kind with an
exclusive focus on publicly-traded companies with market changing
intellectual property (IP).
Misonix was selected from MDB’s 2011 group of “Best and
Brightest” small-cap companies; a group that is advancing some of
today’s most innovative and market-leading IP. Misonix is one
of the 40 public companies ranking in the 90th percentile for its
respective technology leadership from more than 1,500 small-cap
companies with granted U.S. patents, as rated by PatentVest, MDB’s
proprietary IP business intelligence platform.
To learn more about the event, please visit: http://www.mdb.com
About MDB Capital Group
MDB Capital Group, LLC is an institutional research and
investment banking firm focusing exclusively on small and micro-cap
companies possessing market changing, disruptive intellectual
property. For more information on MDB Capital Group, visit:
http://www.mdb.com
About PatentVest
PatenVest® is a proprietary intellectual property (IP)
business intelligence platform developed by MDB Capital Group.
PatentVes
‘/>”/>
SOURCE
